MARTIN MELSON: Open Payments
NPI 1265978944 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 27 payments from 12 companies in 2025. Trend: 2023 $791 · 2024 $1,521 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $173 |
| Novo Nordisk Inc | 7 | $124 |
| ABBVIE INC. | 4 | $87 |
| PFIZER INC. | 3 | $62 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Dexcom, Inc. | 2 | $47 |
| Inspire Medical Systems, Inc. | 1 | $45 |
| Exact Sciences Corporation | 2 | $42 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Gilead Sciences, Inc. | 1 | $23 |
Products named: TZIELD, Ozempic, Rybelsus, Dexcom G6 Transmitter, INSPIRE, NURTEC ODT, Cologuard Collection Kit, QULIPTA.
Industry payments across MD — which companies pay providers there.
